Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 10184Triple Negative Breast Neoplasms 1046Neoplasms 574Ovarian Neoplasms 564Neoplasm Metastasis 515Colorectal Neoplasms 473Carcinoma, Non-Small-Cell Lung 468Prostatic Neoplasms 440Lung Neoplasms 433Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 295Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 227Endometrial Neoplasms 223Head and Neck Neoplasms 218Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 192Squamous Cell Carcinoma of Head and Neck 181Sarcoma 177Urinary Bladder Neoplasms 159Esophageal Neoplasms 155Brain Neoplasms 155Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 130

Interventions

trastuzumab deruxtecan 2neratinib 1Radiosurgery 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Cancer With Brain Metastasis × Breast × Clear all
NCT07152782 2025-09-03

THUNDER

Fudan University

Phase 2 Not yet recruiting
202 enrolled
Breast

Breast Cancer With Brain Metastasis

NCT07150208 2025-09-02

THUMB

Fudan University

Phase 2 Not yet recruiting
140 enrolled
Breast

Breast Cancer With Brain Metastasis

NCT01924351 2020-03-18

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

University of Maryland, Baltimore

Phase 2 Withdrawn
Breast

Breast Cancer With Brain Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡